VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EXPOExponent, Inc.
$60.83$3.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksEXPOCash Flow

Exponent, Inc. (EXPO) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow volatility remains a concern, as evidenced by a swing from a 56.4% margin in 2023Q4 to a negative 2.1% margin in 2026Q1, largely driven by lumpy working capital outflows.

EXPO Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJan'26Jan'25Dec'23Dec'22Dec'21Jan'21Jan'20Dec'18Dec'17Dec'16Jan'16Jan'15Jan'14Dec'12Dec'11Dec'10Jan'10Jan'09Dec'07Dec'06Dec'05Dec'04Jan'04Jan'03Dec'01Dec'00Dec'99Jan'99Jan'98Jan'97
Cash from Operations123.48M131.73M144.54M127.35M93.81M124.57M103.31M108.06M91.19M67.84M66.95M60.49M48.25M61.79M48.51M46.6M36.05M26.82M36.37M26.95M19.58M13.81M16.04M21.66M16.27M4.77M21.05M10.63M1.2M3.6M4.4M
Operating CF Margin %-22.63%25.88%23.73%18.28%26.72%25.83%25.9%24.03%19.5%21.25%19.34%15.84%20.86%16.57%17.1%14.49%11.77%15.89%13.14%11.62%8.9%10.59%15.51%12.9%4.56%20.72%11.39%1.4%4.9%7.5%
Operating CF Growth %-129.42%-8.86%13.49%35.76%-24.69%20.57%-4.39%18.5%34.42%1.33%10.67%25.36%-21.91%27.39%4.1%29.25%34.44%-26.26%34.95%37.63%41.74%-13.86%-25.97%33.19%241.15%-77.35%98.07%785.67%-66.67%-18.18%-42.11%
Net Income108.93M106.01M109M100.34M102.33M101.2M82.55M82.46M72.25M41.3M47.48M43.6M40.7M38.64M37.23M32.7M27.52M22.13M23.16M20.34M14.19M14.19M12.04M10.17M7.92M6.12M7.78M5.19M4.1M4.3M-400K
Depreciation & Amortization10.11M10.08M9.69M8.92M7.08M6.49M6.87M6.81M6.29M6.29M6.13M5.48M5.4M4.95M4.71M4.41M4.32M4.35M4.11M4.79M4.47M4.47M4.09M3.37M3.42M4.68M4.43M4.42M4.5M3.6M3.6M
Stock-Based Compensation24.67M23.8M23.24M20.36M20.36M19.26M17.28M17.47M16.99M16.16M13.33M12.96M13.08M13.17M12.38M10.34M9.26M7.93M7.83M632K-1M2.07M256K044K000000
Deferred Taxes-3.56M-9.95M-3.3M85K-7.36M-6M-3.64M-2.85M-3.71M11.79M-2.6M-10.22M-11.18M-7.67M-8.14M-6.04M-3.23M-4.1M-1.34M-2.65M-3.16M-1.48M-1.44M227K683K101K-154K-53K-800K-1.1M-1.8M
Other Non-Cash Items3M2.99M4.45M3.23M3.08M1.95M1.69M1.71M1.91M2.14M2.11M1.46M2.33M2.85M2.01M1.91M-1.67M436K-2.13M4.72M5.13M2.28M4.77M2.44M2.44M1.73M1.57M2.36M-100K-400K4M
Working Capital Changes-19.67M-1.2M1.46M-5.57M-31.68M1.67M-1.44M2.46M-2.54M-9.84M490K7.22M-2.08M9.85M320K3.28M-146K-3.93M4.74M-875K-60K-7.72M-3.67M5.46M1.75M-7.86M7.42M-1.28M-7.2M-2.8M-1M
Change in Receivables-33.55M-23.09M1.5M-471K-33.33M-30.25M6.72M-16.55M2.44M-25.2M-1.28M-3.14M-11.11M6.68M-14.06M-3.02M-11.18M-4.37M-5.14M-14.1M-3.63M-8.78M-4.59M0952K000000
Change in Inventory00000008.55M-1.23M8.7M2.32M3.06M1.42M69K6.29M997K176K06.42M8.61M2.07M8.98M5.1M0-1.18M000000
Change in Payables2.18M7.68M436K-5.05M2.21M8.44M-2.65M6.71M-4.62M5.98M-370K7.72M6.14M3M7.37M-997K9.48M03.75M5.48M1.56M-194K-514K0224K000000
Cash from Investing-10.09M-9.39M-6.94M-16.36M-12.04M38.18M5.02M4.27M-25.82M-17.72M-27.44M-27.04M2.44M-18.88M-1.17M-29.35M4.93M16.14M21.06M-3.92M-795K-4.35M-34.24M-24.71M-4.29M-2.25M-8.09M-581K500K1.5M-6.9M
Capital Expenditures-10.09M-9.39M-6.94M-16.36M-12.04M-6.83M-4.99M-23.04M-16.3M-4.72M-14.39M-5.38M-4.95M-6.23M-4.94M-3.83M-2.48M-2.02M-5.65M-3.68M-3.21M-3.02M-2.62M-2.32M-2.14M-2.19M-8.69M-4.97M-5.8M-4.2M-3M
CapEx % of Revenue1.67%1.61%1.24%3.05%2.35%1.46%1.25%5.52%4.29%1.36%4.57%1.72%1.62%2.1%1.69%1.41%1%0.89%2.47%1.79%1.9%1.94%1.73%1.66%1.7%2.1%8.55%5.33%6.78%5.71%5.11%
Acquisitions000000023.04M0000000000000000-2.13M000000
Investments-------------------------------
Other Investing0000000-23.04M-9.52M-13M-13.05M-21.66M7.38M-12.65M3.77M000090K57K8K264K-125K-17K-59K603K-21K0-8.1M-900K
Cash from Financing-240.06M-160.43M-65.11M-86.01M-215.98M-62.75M-88.36M-63.41M-62.5M-41.26M-49.17M-36.92M-43.13M-33.77M-18.86M-39.34M-2.22M-7.76M-34.06M-17.63M-26.97M-869K5.65M17K2.69M-1.08M-6.58M-16.13M-4M-1.1M-500K
Debt Issued (Net)000000000000000000-56K-51K-52K-61K-65K-78K-350K-111K-4M-12.78M-1.6M-2M200K
Equity Issued (Net)-174.21M-94.72M-5.71M-22.02M-153.84M-7M-40.05M-18.73M-27.91M-11.93M-24.46M-23.31M-30.92M-25.52M-22.89M-40.57M-7.14M-12.88M-39.56M-21.57M-27.79M-808K5.71M95K3.04M-1.26M-2.6M-3.35M-2.5M900K-600K
Dividends Paid-61.75M-61.54M-58.21M-54.04M-49.24M-43.2M-39.77M-33.5M-27.22M-21.84M-18.78M-15.65M-13.06M-7.93M00000000000000000
Share Repurchases-175.86M-97.09M-5.71M-24.21M-155.86M-7M-40.05M-21.96M-27.91M-11.93M-24.46M-23.31M-30.92M-25.52M-22.89M-40.57M-7.14M-12.88M-41.64M-24.65M-30.09M-4.31M0-2.45M-1.62M-3.81M-4.16M-4.37M-3.4M0-1M
Other Financing-4.09M-4.17M-1.18M-9.94M-12.9M-12.55M-8.53M-11.18M-7.37M-7.5M-5.93M2.04M851K-323K4.03M1.23M4.92M5.12M5.55M3.99M869K0000289K15K0100K0-100K
Net Change in Cash-126.56M-36.97M71.75M25.69M-136.23M100.16M21.09M49.38M2.27M9.83M-10.78M-3.74M6.54M9.68M28.83M-22.11M38.65M35.3M21.9M5.46M-7.98M8.54M-12.51M-2.99M14.66M1.44M6.38M-6.08M-2.3M4M-3M
Free Cash Flow113.39M122.34M137.6M111M81.76M117.74M98.33M85.02M74.89M63.11M52.55M55.11M43.3M55.57M43.56M42.76M33.58M24.8M30.72M23.27M16.38M10.8M13.42M19.35M14.13M2.58M12.36M5.66M-4.6M-600K1.4M
FCF Margin %18.81%21.02%24.64%20.68%15.93%25.25%24.59%20.38%19.73%18.15%16.68%17.62%14.21%18.76%14.89%15.7%13.5%10.88%13.43%11.34%9.72%6.96%8.86%13.85%11.21%2.47%12.17%6.07%-5.38%-0.82%2.38%
FCF Growth %-15.49%-11.09%23.97%35.75%-30.56%19.75%15.65%13.53%18.66%20.09%-4.64%27.26%-22.07%27.55%1.88%27.35%35.4%-19.28%32.01%42.11%51.64%-19.54%-30.62%36.93%448.49%-79.16%118.49%222.98%-666.67%-142.86%-77.42%
FCF per Share2.262.392.672.151.562.211.841.581.381.170.971.010.780.990.760.720.560.410.490.360.240.150.200.300.230.040.220.10-0.07-0.010.03
FCF Conversion (FCF/Net Income)1.04x1.24x1.33x1.27x0.92x1.23x1.25x1.31x1.26x1.64x1.41x1.39x1.19x1.60x1.30x1.43x1.31x1.21x1.57x1.32x1.38x0.97x1.33x2.13x2.05x0.78x2.71x2.05x0.29x0.84x-11.00x
Interest Paid0000000000000000000000000000000
Taxes Paid30.91M0038.94M40.12M27.91M20.12M028.64M25.85M22.28M24.65M27.42M24.7M24.1M21.67M19.46M00000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Working Capital Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Accruals

As reported in recent financial statements, Exponent's operating cash flow to net income ratio has fluctuated wildly, reaching a low of -0.03 in 2026Q1, which suggests that reported earnings are frequently decoupled from actual cash generation due to significant timing differences in project-based revenue recognition.

The extreme variance in the OCF/NI ratio indicates that net income is a poor proxy for short-term liquidity in this business model. Investors should monitor whether these accrual-heavy periods represent genuine delays in client payments or structural shifts in how the firm recognizes revenue across its multi-year litigation engagements.

FCF Volatility Driven by Seasonality

Based on the provided cash flow data, Exponent's free cash flow margins exhibit extreme cyclicality, swinging from a negative 2.1% in 2026Q1 to a robust 56.4% in 2023Q4, highlighting the inherent unpredictability of cash conversion in a project-based forensic consulting firm.

The sharp contraction in FCF during the first quarter of each year appears to be a recurring pattern, likely tied to the timing of annual bonus payouts and working capital cycles. This volatility suggests that the firm's cash generation is highly sensitive to the specific cadence of large-scale forensic projects.

Working Capital Swings Impact Liquidity

According to quarterly cash flow filings, Exponent experienced a significant working capital outflow of $45.5 million in 2026Q1, a sharp reversal from the $42.9 million inflow seen in 2023Q4, which underscores the firm's vulnerability to lumpy client payment cycles and project-related inventory build-ups.

The magnitude of these working capital swings suggests that the firm's cash position is heavily dependent on the timing of milestone billings for major forensic investigations. Such fluctuations may indicate that the firm is effectively acting as a short-term lender to its clients during the pendency of complex litigation.

Aggressive Capital Return Strategy Maintained

As evidenced by recent financial disclosures, Exponent has prioritized shareholder returns, with $78.8 million deployed toward share repurchases in 2026Q1 alone, despite the firm's simultaneous experience of negative free cash flow during that same period, suggesting a high degree of confidence in its underlying liquidity.

The decision to maintain aggressive buybacks while operating cash flow is temporarily negative implies that management relies on its substantial cash reserves to smooth out capital allocation. Investors should monitor whether this strategy remains sustainable if the current volatility in working capital persists over a longer duration.

EXPO — Frequently Asked Questions

Quick answers to the most common questions about buying EXPO stock.

How much cash does Exponent, Inc. (EXPO) generate from operations?

Exponent, Inc. (EXPO) generated $131.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Exponent, Inc.'s free cash flow?

Exponent, Inc. (EXPO) generated $122.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Exponent, Inc.'s capital expenditure (CapEx)?

Exponent, Inc. (EXPO) spent $9.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Exponent, Inc. distribute cash to shareholders?

In 2025, Exponent, Inc. (EXPO) returned $61.5M to shareholders via cash dividends and spent $97.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.